ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bullish•Cross Asset Strategy
•27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
439 Views
Share
bearish•Bombardier Inc
•16 Nov 2018 11:07

Reality Overwhelms Creative Accounting

Bombardier Inc (BBD/B CN) has recently fallen 38%, ThyssenKrupp AG (TKA GR) 18%  and Celltrion Inc (068270 KS) 30%.  In each case, the market was...

bullish•Samsung C&T
•15 Nov 2018 08:12

Samsung BioLogics Trade Suspension: Short Celltrion/Long Samsung C&T

The FSC said it had found intentionality behind BioLogics’ breach of accounting rules. Hence, the FSC pressed criminal charges against BioLogics...

Logo
602 Views
Share
•31 Oct 2018 21:23

Korea Stock Market Monthly Recap #30 (October 2018)

The Korean stock market fell sharply in October and KOSPI is down 13% this month. Nikkei is down 9% and S&P 500 is down 8% this month as well....

Logo
614 Views
Share
•29 Oct 2018 13:52

Smartkarma’s Week That Was in JP/​​​​KR: Market Turbulence 10 Years After 2008, Coway, & Celltrion

The Korean and Japanese stock markets have fallen sharply in October. Nikkei is down 12% and KOSPI is down 14% in October. It has been 10 years...

Logo
413 Views
Share
x